TEONA NUTSUBIDZE
Teona Nutsubidze
Endocrinologist
Doctor Teona Nutsubidze is an endocrinologist at the National Institute of Endocrinology and a consulting doctor at Cito Medical Centre. She is also an assistant professor and PhD student at Tbilisi State University, specializing in translational medicine. Dr. Teona Nutsubidze serves as President of the Georgian Endocrinology Alliance (GEA) and is an active member of several international endocrine societies. Her professional interests include clinical endocrinology and participation in international clinical research projects. Teona Nutsubidze is the author of several publications and has received various professional certificates over the years.
Office Hours:
Current Positions
- Endocrinologist – National Institute of Endocrinology, Tbilisi, Georgia (From February 2022 – present)
- PhD Student – Tbilisi State University, Tbilisi, Georgia (From September 2022 – present)
- Assistant Professor – National Institute of Endocrinology, Tbilisi, Georgia (From September 2019 – present)
- President – Georgian Endocrinology Alliance (GEA), Tbilisi, Georgia (From June 2024 – present)
- Consulting Doctor (Endocrinologist) – Cito Medical Centre, Tbilisi, Georgia (From February 2025 – present)
Education & Scientific Degrees
Doctor of Medicine (MD) – Tbilisi State Medical University, Tbilisi, Georgia (June 2016) ▪ Full state scholarship for excellent academic performance ▪ University Scholarship (2014) ▪ Presidential Scholarship (2015–2016)
Doctor Endocrinologist – National Institute of Endocrinology, Tbilisi, Georgia (February 2022) ▪ Full scholarship named after Prof. V. Chachibaia PhD Student (Translational Medicine) – Tbilisi State University, Tbilisi, Georgia (From September 2022 – present) SCOPE Certified Health Professional (May 2025)
Professional Memberships
- Member, Scientific Committee, European Society of Paediatric Endocrinology (ESPE)
- Member, American Endocrine Society (ENDO)
- Member, European Society of Endocrinology (ESE)
- Member, EASO Early Career Network (ECN)
- Member, Society for Endocrinology
Clinical Trials
2018–2021:Randomised, double-blind, placebo-controlled phase II study Evaluation of Filgotinib’s effect on semen parameters in males with active rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, or non-radiographic axial spondyloarthritis.
2023–2024:Double-blind, randomised, placebo-controlled phase IIb study Efficacy and safety of norursodeoxycholic acid tablets in patients with nonalcoholic steatohepatitis (NASH). Role: Sub-investigator
Service
List of Services